Ocean Biomedical Stock Today

OCEAW Stock   0.04  0.0007  1.82%   

Performance

9 of 100

 
Weak
 
Strong
OK

Odds Of Distress

Over 57

 
High
 
Low
Above Average
Ocean Biomedical is selling for under 0.0392 as of the 25th of November 2024; that is 1.82% up since the beginning of the trading day. The stock's lowest day price was 0.0392. Ocean Biomedical has over 57 % chance of experiencing financial distress in the next 2 years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Ocean Biomedical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of February 2024 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
5th of November 2021
Category
Healthcare
Classification
Health Care
Ocean Biomedical is entity of United States. It is traded as Stock on NASDAQ exchange. More on Ocean Biomedical

Ocean Stock Highlights

Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities3.5 MM
Fairly Down
Slightly volatile
Ocean Biomedical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ocean Biomedical's financial leverage. It provides some insight into what part of Ocean Biomedical's total assets is financed by creditors.
Liquidity
Ocean Biomedical has accumulated 2.15 M in total debt. Note, when we think about Ocean Biomedical's use of debt, we should always consider it together with its cash and equity.

Change In Cash

(638,939)
Ocean Biomedical (OCEAW) is traded on NASDAQ Exchange in USA. It is located in null and employs 9 people. Ocean Biomedical is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry. Ocean Biomedical generates negative cash flow from operations
Check Ocean Biomedical Probability Of Bankruptcy

Ocean Biomedical Historical Income Statement

At this time, Ocean Biomedical's Depreciation And Amortization is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 34.3 M in 2024, whereas Operating Income is likely to drop (2.3 M) in 2024. View More Fundamentals

Ocean Stock Against Markets

Additional Tools for Ocean Stock Analysis

When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.